top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
Texas Gov. Greg Abbott signed a bill to create a state-backed research consortium for ibogaine trials for substance use disorders. The goal is to develop ibogaine into an FDA-approved drug, with the state retaining a portion of the profit. Texas will invest $50 million in the research, with potential for grants and private investments. The state will retain a commercial interest in intellectual property from the trials, with a quarter of revenue funding veterans programs. The new law seeks FDA approval and a "breakthrough therapy designation" for ibogaine.

Texas Governor Signs Ibogaine Development Bill

Jun 11, 2025

Source:

Ben Adlin

Marijuana Moment

Texas is making a major move into the world of psychedelics, and it's not just talk. Governor Greg Abbott recently signed a law to create a state-backed research group focused on ibogaine. The goal is to turn this powerful psychedelic into an FDA-approved prescription drug to treat things like PTSD and opioid addiction, with the state even investing $50 million to kickstart the trials.

This is a massive development for the community because it shows that even conservative leadership is recognizing the therapeutic potential of alternative medicines. While we’re usually focused on the herb, seeing a state like Texas embrace psychedelic research is a huge win for mental health and accessibility. It suggests a shifting tide where science-backed natural treatments are finally getting the serious attention they deserve. For everyday users, this could eventually mean safer, legal access to life-changing therapies that were once pushed into the shadows. It’s a sign that the "just say no" era is fading as practical, plant-based solutions take center stage.

Recent Reviews

bottom of page